WHO Grade 3 Glioma Active Not Recruiting Phase 2 Trials for Temozolomide (DB00853)

Also known as: WHO Grade III Gliomas / Grade III Glioma / WHO Grade III Glioma

IndicationStatusPhase
DBCOND0146359 (WHO Grade 3 Glioma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03180502Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III GliomaSupportive Care